Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Kiviniemi A, Gardberg M, Autio A, Li XG, Heuser VD, Liljenbäck H, Käkelä M, Sipilä H, Kurkipuro J, Ylä-Herttuala S, Knuuti J, Minn H, Roivainen A.
Kiviniemi A, et al. Among authors: gardberg m.
Acta Oncol. 2014 Aug;53(8):1125-34. doi: 10.3109/0284186X.2014.925577. Epub 2014 Jun 24.
Acta Oncol. 2014.
PMID: 24957558